[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global PRRS Vaccines Market Research Report 2024(Status and Outlook)

August 2024 | 142 pages | ID: GCD2664604FDEN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview

There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.

This report provides a deep insight into the global PRRS Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PRRS Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PRRS Vaccines market in any manner.

Global PRRS Vaccines Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

CAHIC

Merial

MSD Animal Health

Chopper Biology

Ceva

ChengDu Tecbond

Veterinary

Ringpu Biology

Qilu Animal

DHN

CAVAC

Komipharm

Agrovet

Bioveta

Jinyu Bio-Technology

Institutul Pasteur

MVP

Tecon

Zoetis

Market Segmentation (by Type)

Live Vaccines

Killed Vaccines

Market Segmentation (by Application)

Government Tender

Market Sales

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the PRRS Vaccines Market
  • Overview of the regional outlook of the PRRS Vaccines Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PRRS Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of PRRS Vaccines
1.2 Key Market Segments
  1.2.1 PRRS Vaccines Segment by Type
  1.2.2 PRRS Vaccines Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PRRS VACCINES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global PRRS Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global PRRS Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PRRS VACCINES MARKET COMPETITIVE LANDSCAPE

3.1 Global PRRS Vaccines Sales by Manufacturers (2019-2024)
3.2 Global PRRS Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PRRS Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers PRRS Vaccines Sales Sites, Area Served, Product Type
3.6 PRRS Vaccines Market Competitive Situation and Trends
  3.6.1 PRRS Vaccines Market Concentration Rate
  3.6.2 Global 5 and 10 Largest PRRS Vaccines Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 PRRS VACCINES INDUSTRY CHAIN ANALYSIS

4.1 PRRS Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PRRS VACCINES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 PRRS VACCINES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PRRS Vaccines Sales Market Share by Type (2019-2024)
6.3 Global PRRS Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global PRRS Vaccines Price by Type (2019-2024)

7 PRRS VACCINES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PRRS Vaccines Market Sales by Application (2019-2024)
7.3 Global PRRS Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global PRRS Vaccines Sales Growth Rate by Application (2019-2024)

8 PRRS VACCINES MARKET SEGMENTATION BY REGION

8.1 Global PRRS Vaccines Sales by Region
  8.1.1 Global PRRS Vaccines Sales by Region
  8.1.2 Global PRRS Vaccines Sales Market Share by Region
8.2 North America
  8.2.1 North America PRRS Vaccines Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe PRRS Vaccines Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific PRRS Vaccines Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America PRRS Vaccines Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa PRRS Vaccines Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 CAHIC
  9.1.1 CAHIC PRRS Vaccines Basic Information
  9.1.2 CAHIC PRRS Vaccines Product Overview
  9.1.3 CAHIC PRRS Vaccines Product Market Performance
  9.1.4 CAHIC Business Overview
  9.1.5 CAHIC PRRS Vaccines SWOT Analysis
  9.1.6 CAHIC Recent Developments
9.2 Merial
  9.2.1 Merial PRRS Vaccines Basic Information
  9.2.2 Merial PRRS Vaccines Product Overview
  9.2.3 Merial PRRS Vaccines Product Market Performance
  9.2.4 Merial Business Overview
  9.2.5 Merial PRRS Vaccines SWOT Analysis
  9.2.6 Merial Recent Developments
9.3 MSD Animal Health
  9.3.1 MSD Animal Health PRRS Vaccines Basic Information
  9.3.2 MSD Animal Health PRRS Vaccines Product Overview
  9.3.3 MSD Animal Health PRRS Vaccines Product Market Performance
  9.3.4 MSD Animal Health PRRS Vaccines SWOT Analysis
  9.3.5 MSD Animal Health Business Overview
  9.3.6 MSD Animal Health Recent Developments
9.4 Chopper Biology
  9.4.1 Chopper Biology PRRS Vaccines Basic Information
  9.4.2 Chopper Biology PRRS Vaccines Product Overview
  9.4.3 Chopper Biology PRRS Vaccines Product Market Performance
  9.4.4 Chopper Biology Business Overview
  9.4.5 Chopper Biology Recent Developments
9.5 Ceva
  9.5.1 Ceva PRRS Vaccines Basic Information
  9.5.2 Ceva PRRS Vaccines Product Overview
  9.5.3 Ceva PRRS Vaccines Product Market Performance
  9.5.4 Ceva Business Overview
  9.5.5 Ceva Recent Developments
9.6 ChengDu Tecbond
  9.6.1 ChengDu Tecbond PRRS Vaccines Basic Information
  9.6.2 ChengDu Tecbond PRRS Vaccines Product Overview
  9.6.3 ChengDu Tecbond PRRS Vaccines Product Market Performance
  9.6.4 ChengDu Tecbond Business Overview
  9.6.5 ChengDu Tecbond Recent Developments
9.7 Veterinary
  9.7.1 Veterinary PRRS Vaccines Basic Information
  9.7.2 Veterinary PRRS Vaccines Product Overview
  9.7.3 Veterinary PRRS Vaccines Product Market Performance
  9.7.4 Veterinary Business Overview
  9.7.5 Veterinary Recent Developments
9.8 Ringpu Biology
  9.8.1 Ringpu Biology PRRS Vaccines Basic Information
  9.8.2 Ringpu Biology PRRS Vaccines Product Overview
  9.8.3 Ringpu Biology PRRS Vaccines Product Market Performance
  9.8.4 Ringpu Biology Business Overview
  9.8.5 Ringpu Biology Recent Developments
9.9 Qilu Animal
  9.9.1 Qilu Animal PRRS Vaccines Basic Information
  9.9.2 Qilu Animal PRRS Vaccines Product Overview
  9.9.3 Qilu Animal PRRS Vaccines Product Market Performance
  9.9.4 Qilu Animal Business Overview
  9.9.5 Qilu Animal Recent Developments
9.10 DHN
  9.10.1 DHN PRRS Vaccines Basic Information
  9.10.2 DHN PRRS Vaccines Product Overview
  9.10.3 DHN PRRS Vaccines Product Market Performance
  9.10.4 DHN Business Overview
  9.10.5 DHN Recent Developments
9.11 CAVAC
  9.11.1 CAVAC PRRS Vaccines Basic Information
  9.11.2 CAVAC PRRS Vaccines Product Overview
  9.11.3 CAVAC PRRS Vaccines Product Market Performance
  9.11.4 CAVAC Business Overview
  9.11.5 CAVAC Recent Developments
9.12 Komipharm
  9.12.1 Komipharm PRRS Vaccines Basic Information
  9.12.2 Komipharm PRRS Vaccines Product Overview
  9.12.3 Komipharm PRRS Vaccines Product Market Performance
  9.12.4 Komipharm Business Overview
  9.12.5 Komipharm Recent Developments
9.13 Agrovet
  9.13.1 Agrovet PRRS Vaccines Basic Information
  9.13.2 Agrovet PRRS Vaccines Product Overview
  9.13.3 Agrovet PRRS Vaccines Product Market Performance
  9.13.4 Agrovet Business Overview
  9.13.5 Agrovet Recent Developments
9.14 Bioveta
  9.14.1 Bioveta PRRS Vaccines Basic Information
  9.14.2 Bioveta PRRS Vaccines Product Overview
  9.14.3 Bioveta PRRS Vaccines Product Market Performance
  9.14.4 Bioveta Business Overview
  9.14.5 Bioveta Recent Developments
9.15 Jinyu Bio-Technology
  9.15.1 Jinyu Bio-Technology PRRS Vaccines Basic Information
  9.15.2 Jinyu Bio-Technology PRRS Vaccines Product Overview
  9.15.3 Jinyu Bio-Technology PRRS Vaccines Product Market Performance
  9.15.4 Jinyu Bio-Technology Business Overview
  9.15.5 Jinyu Bio-Technology Recent Developments
9.16 Institutul Pasteur
  9.16.1 Institutul Pasteur PRRS Vaccines Basic Information
  9.16.2 Institutul Pasteur PRRS Vaccines Product Overview
  9.16.3 Institutul Pasteur PRRS Vaccines Product Market Performance
  9.16.4 Institutul Pasteur Business Overview
  9.16.5 Institutul Pasteur Recent Developments
9.17 MVP
  9.17.1 MVP PRRS Vaccines Basic Information
  9.17.2 MVP PRRS Vaccines Product Overview
  9.17.3 MVP PRRS Vaccines Product Market Performance
  9.17.4 MVP Business Overview
  9.17.5 MVP Recent Developments
9.18 Tecon
  9.18.1 Tecon PRRS Vaccines Basic Information
  9.18.2 Tecon PRRS Vaccines Product Overview
  9.18.3 Tecon PRRS Vaccines Product Market Performance
  9.18.4 Tecon Business Overview
  9.18.5 Tecon Recent Developments
9.19 Zoetis
  9.19.1 Zoetis PRRS Vaccines Basic Information
  9.19.2 Zoetis PRRS Vaccines Product Overview
  9.19.3 Zoetis PRRS Vaccines Product Market Performance
  9.19.4 Zoetis Business Overview
  9.19.5 Zoetis Recent Developments

10 PRRS VACCINES MARKET FORECAST BY REGION

10.1 Global PRRS Vaccines Market Size Forecast
10.2 Global PRRS Vaccines Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe PRRS Vaccines Market Size Forecast by Country
  10.2.3 Asia Pacific PRRS Vaccines Market Size Forecast by Region
  10.2.4 South America PRRS Vaccines Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of PRRS Vaccines by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global PRRS Vaccines Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of PRRS Vaccines by Type (2025-2030)
  11.1.2 Global PRRS Vaccines Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of PRRS Vaccines by Type (2025-2030)
11.2 Global PRRS Vaccines Market Forecast by Application (2025-2030)
  11.2.1 Global PRRS Vaccines Sales (K Units) Forecast by Application
  11.2.2 Global PRRS Vaccines Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PRRS Vaccines Market Size Comparison by Region (M USD)
Table 5. Global PRRS Vaccines Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global PRRS Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global PRRS Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global PRRS Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PRRS Vaccines as of 2022)
Table 10. Global Market PRRS Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers PRRS Vaccines Sales Sites and Area Served
Table 12. Manufacturers PRRS Vaccines Product Type
Table 13. Global PRRS Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PRRS Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PRRS Vaccines Market Challenges
Table 22. Global PRRS Vaccines Sales by Type (K Units)
Table 23. Global PRRS Vaccines Market Size by Type (M USD)
Table 24. Global PRRS Vaccines Sales (K Units) by Type (2019-2024)
Table 25. Global PRRS Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global PRRS Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global PRRS Vaccines Market Size Share by Type (2019-2024)
Table 28. Global PRRS Vaccines Price (USD/Unit) by Type (2019-2024)
Table 29. Global PRRS Vaccines Sales (K Units) by Application
Table 30. Global PRRS Vaccines Market Size by Application
Table 31. Global PRRS Vaccines Sales by Application (2019-2024) & (K Units)
Table 32. Global PRRS Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global PRRS Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global PRRS Vaccines Market Share by Application (2019-2024)
Table 35. Global PRRS Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global PRRS Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Global PRRS Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America PRRS Vaccines Sales by Country (2019-2024) & (K Units)
Table 39. Europe PRRS Vaccines Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific PRRS Vaccines Sales by Region (2019-2024) & (K Units)
Table 41. South America PRRS Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa PRRS Vaccines Sales by Region (2019-2024) & (K Units)
Table 43. CAHIC PRRS Vaccines Basic Information
Table 44. CAHIC PRRS Vaccines Product Overview
Table 45. CAHIC PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. CAHIC Business Overview
Table 47. CAHIC PRRS Vaccines SWOT Analysis
Table 48. CAHIC Recent Developments
Table 49. Merial PRRS Vaccines Basic Information
Table 50. Merial PRRS Vaccines Product Overview
Table 51. Merial PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Merial Business Overview
Table 53. Merial PRRS Vaccines SWOT Analysis
Table 54. Merial Recent Developments
Table 55. MSD Animal Health PRRS Vaccines Basic Information
Table 56. MSD Animal Health PRRS Vaccines Product Overview
Table 57. MSD Animal Health PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. MSD Animal Health PRRS Vaccines SWOT Analysis
Table 59. MSD Animal Health Business Overview
Table 60. MSD Animal Health Recent Developments
Table 61. Chopper Biology PRRS Vaccines Basic Information
Table 62. Chopper Biology PRRS Vaccines Product Overview
Table 63. Chopper Biology PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Chopper Biology Business Overview
Table 65. Chopper Biology Recent Developments
Table 66. Ceva PRRS Vaccines Basic Information
Table 67. Ceva PRRS Vaccines Product Overview
Table 68. Ceva PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Ceva Business Overview
Table 70. Ceva Recent Developments
Table 71. ChengDu Tecbond PRRS Vaccines Basic Information
Table 72. ChengDu Tecbond PRRS Vaccines Product Overview
Table 73. ChengDu Tecbond PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. ChengDu Tecbond Business Overview
Table 75. ChengDu Tecbond Recent Developments
Table 76. Veterinary PRRS Vaccines Basic Information
Table 77. Veterinary PRRS Vaccines Product Overview
Table 78. Veterinary PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Veterinary Business Overview
Table 80. Veterinary Recent Developments
Table 81. Ringpu Biology PRRS Vaccines Basic Information
Table 82. Ringpu Biology PRRS Vaccines Product Overview
Table 83. Ringpu Biology PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Ringpu Biology Business Overview
Table 85. Ringpu Biology Recent Developments
Table 86. Qilu Animal PRRS Vaccines Basic Information
Table 87. Qilu Animal PRRS Vaccines Product Overview
Table 88. Qilu Animal PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Qilu Animal Business Overview
Table 90. Qilu Animal Recent Developments
Table 91. DHN PRRS Vaccines Basic Information
Table 92. DHN PRRS Vaccines Product Overview
Table 93. DHN PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. DHN Business Overview
Table 95. DHN Recent Developments
Table 96. CAVAC PRRS Vaccines Basic Information
Table 97. CAVAC PRRS Vaccines Product Overview
Table 98. CAVAC PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. CAVAC Business Overview
Table 100. CAVAC Recent Developments
Table 101. Komipharm PRRS Vaccines Basic Information
Table 102. Komipharm PRRS Vaccines Product Overview
Table 103. Komipharm PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Komipharm Business Overview
Table 105. Komipharm Recent Developments
Table 106. Agrovet PRRS Vaccines Basic Information
Table 107. Agrovet PRRS Vaccines Product Overview
Table 108. Agrovet PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Agrovet Business Overview
Table 110. Agrovet Recent Developments
Table 111. Bioveta PRRS Vaccines Basic Information
Table 112. Bioveta PRRS Vaccines Product Overview
Table 113. Bioveta PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Bioveta Business Overview
Table 115. Bioveta Recent Developments
Table 116. Jinyu Bio-Technology PRRS Vaccines Basic Information
Table 117. Jinyu Bio-Technology PRRS Vaccines Product Overview
Table 118. Jinyu Bio-Technology PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Jinyu Bio-Technology Business Overview
Table 120. Jinyu Bio-Technology Recent Developments
Table 121. Institutul Pasteur PRRS Vaccines Basic Information
Table 122. Institutul Pasteur PRRS Vaccines Product Overview
Table 123. Institutul Pasteur PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Institutul Pasteur Business Overview
Table 125. Institutul Pasteur Recent Developments
Table 126. MVP PRRS Vaccines Basic Information
Table 127. MVP PRRS Vaccines Product Overview
Table 128. MVP PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. MVP Business Overview
Table 130. MVP Recent Developments
Table 131. Tecon PRRS Vaccines Basic Information
Table 132. Tecon PRRS Vaccines Product Overview
Table 133. Tecon PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Tecon Business Overview
Table 135. Tecon Recent Developments
Table 136. Zoetis PRRS Vaccines Basic Information
Table 137. Zoetis PRRS Vaccines Product Overview
Table 138. Zoetis PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Zoetis Business Overview
Table 140. Zoetis Recent Developments
Table 141. Global PRRS Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 142. Global PRRS Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America PRRS Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 144. North America PRRS Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe PRRS Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 146. Europe PRRS Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific PRRS Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 148. Asia Pacific PRRS Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America PRRS Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 150. South America PRRS Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa PRRS Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa PRRS Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global PRRS Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 154. Global PRRS Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global PRRS Vaccines Price Forecast by Type (2025-2030) & (USD/Unit)
Table 156. Global PRRS Vaccines Sales (K Units) Forecast by Application (2025-2030)
Table 157. Global PRRS Vaccines Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of PRRS Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PRRS Vaccines Market Size (M USD), 2019-2030
Figure 5. Global PRRS Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global PRRS Vaccines Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PRRS Vaccines Market Size by Country (M USD)
Figure 11. PRRS Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global PRRS Vaccines Revenue Share by Manufacturers in 2023
Figure 13. PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PRRS Vaccines Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PRRS Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PRRS Vaccines Market Share by Type
Figure 18. Sales Market Share of PRRS Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of PRRS Vaccines by Type in 2023
Figure 20. Market Size Share of PRRS Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of PRRS Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PRRS Vaccines Market Share by Application
Figure 24. Global PRRS Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global PRRS Vaccines Sales Market Share by Application in 2023
Figure 26. Global PRRS Vaccines Market Share by Application (2019-2024)
Figure 27. Global PRRS Vaccines Market Share by Application in 2023
Figure 28. Global PRRS Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global PRRS Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America PRRS Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada PRRS Vaccines Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico PRRS Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe PRRS Vaccines Sales Market Share by Country in 2023
Figure 37. Germany PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific PRRS Vaccines Sales and Growth Rate (K Units)
Figure 43. Asia Pacific PRRS Vaccines Sales Market Share by Region in 2023
Figure 44. China PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America PRRS Vaccines Sales and Growth Rate (K Units)
Figure 50. South America PRRS Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa PRRS Vaccines Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa PRRS Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa PRRS Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global PRRS Vaccines Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global PRRS Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global PRRS Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global PRRS Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global PRRS Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global PRRS Vaccines Market Share Forecast by Application (2025-2030)


More Publications